ClinicaliQ Trial Snapshot
- Safe and Timely Antithrombotic Removal (STAR) Registry — Active Not Recruiting • NCT05077124.
- CytoSorb device use for removing blood-thinning drugs: real-world safety and effectiveness data collection.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This registry will capture real-world clinical use patterns and associated clinical outcomes with the use of CytoSorb for the removal of antithrombotic agents. Conditions: Hemorrhage, Surgical, Hemorrhage Postoperative, Blood Loss, Surgical, Blood Loss, Postoperative Interventions: CytoSorb Lead Sponsor: CytoSorbents, Inc Planned Enrollment: 1000 participants